PMID- 2869809 OWN - NLM STAT- MEDLINE DCOM- 19860514 LR - 20190510 IS - 0007-1188 (Print) IS - 0007-1188 (Linking) VI - 87 IP - 1 DP - 1986 Jan TI - Dermorphin analogues containing D-kyotorphin: structure-antinociceptive relationships in mice. PG - 183-9 AB - The antinociceptive effects of synthetic dermorphin and its analogues containing D-Arg in position 2 injected into the lateral cerebroventricle were examined in conscious mice. Intracerebroventricular (i.c.v.) administration of dermorphin and [D-Arg2] dermorphin produced potent and long-lasting antinociceptive activity as assayed by the tail-pressure test. Dermorphin and [D-Arg2] dermorphin were 210 and 52 times more potent than morphine, respectively. The antinociceptive effects produced by these heptapeptides were antagonized by a low dose (0.5 mg kg-1, i.p.) of the opioid antagonist naloxone. The ED50 values for [D-Arg2] dermorphin (1-6), (1-5) and (1-4) were not significantly different from that for [D-Arg2] dermorphin. The potency of the shortest fragment, [D-Arg2] dermorphin (1-2) was found to possess a severely reduced activity, whilst [D-Arg2] dermorphin (1-3) maintained activity and was 10 times more potent than morphine. [D-Arg2] dermorphin analogues showed almost identical effects when tested on the electrically-induced contractions of the guinea-pig isolated ileum. These results led us to conclude that the presence of the N-terminal tripeptide in the structure of [D-Arg2] dermorphin is of crucial importance for the manifestation of the full intrinsic opioid-like antinociceptive activity of [D-Arg2] dermorphin, which is presumably mediated through opioid receptors in the brain. FAU - Kisara, K AU - Kisara K FAU - Sakurada, S AU - Sakurada S FAU - Sakurada, T AU - Sakurada T FAU - Sasaki, Y AU - Sasaki Y FAU - Sato, T AU - Sato T FAU - Suzuki, K AU - Suzuki K FAU - Watanabe, H AU - Watanabe H LA - eng PT - Journal Article PL - England TA - Br J Pharmacol JT - British journal of pharmacology JID - 7502536 RN - 0 (Analgesics, Opioid) RN - 0 (Oligopeptides) RN - 0 (Opioid Peptides) RN - 0 (Peptide Fragments) RN - 2SEC01B703 (dermorphin) RN - 96425-96-6 (dermorphin, Arg(2)-) SB - IM MH - Analgesics, Opioid/*pharmacology MH - Animals MH - Dose-Response Relationship, Drug MH - Electric Stimulation MH - Guinea Pigs MH - Ileum/drug effects MH - In Vitro Techniques MH - Male MH - Mice MH - Muscle Contraction/drug effects MH - Oligopeptides/*pharmacology MH - Opioid Peptides MH - Peptide Fragments/pharmacology MH - Structure-Activity Relationship PMC - PMC1916917 EDAT- 1986/01/01 00:00 MHDA- 1986/01/01 00:01 PMCR- 1987/01/01 CRDT- 1986/01/01 00:00 PHST- 1986/01/01 00:00 [pubmed] PHST- 1986/01/01 00:01 [medline] PHST- 1986/01/01 00:00 [entrez] PHST- 1987/01/01 00:00 [pmc-release] AID - 10.1111/j.1476-5381.1986.tb10170.x [doi] PST - ppublish SO - Br J Pharmacol. 1986 Jan;87(1):183-9. doi: 10.1111/j.1476-5381.1986.tb10170.x.